购物车
- 全部删除
- 您的购物车当前为空
DPP-4-IN-13 (compound 9i) 作为竞争性DPP4抑制剂,展现出9.25 μM的IC50,适于2型糖尿病研究应用。
DPP-4-IN-13 (compound 9i) 作为竞争性DPP4抑制剂,展现出9.25 μM的IC50,适于2型糖尿病研究应用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | DPP-4-IN-13 (compound 9i) is a competitive inhibitor of DPP4, exhibiting an IC50 of 9.25 μM, making it suitable for research in type 2 diabetes. |
分子量 | 571.85 |
分子式 | C25H24BrClN6O3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容